Company intelligence / Profile preview

Growth AB

Stockholm, Sweden

Ownership: Private
Development stage: Other

Overview

Growth AB is a Swedish-based investment and holding company that focuses on the life sciences and healthcare sectors. The company primarily operates as a vehicle for strategic investments in emerging biotechnology and medical technology firms, providing capital and management expertise to foster growth. While it does not maintain an internal drug development pipeline, it plays a critical role in the Scandinavian biotech ecosystem by supporting the commercialization of innovative medical solutions. Its portfolio typically includes companies specializing in diagnostics, medical devices, and specialized healthcare services.

Industry: Investors

Beyond the preview

Go deeper on Growth AB.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Growth AB.

Explore the full profile